Detalhe da pesquisa
1.
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.
Blood
; 139(1): 87-103, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320176
2.
Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens.
Haematologica
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38654660
3.
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes.
Am J Hematol
; 99(2): E32-E36, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994196
4.
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4.
Haematologica
; 108(1): 34-41, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35678031
5.
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
Ann Hematol
; 102(3): 547-561, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36695874
6.
Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
Blood
; 136(7): 823-830, 2020 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32496541
7.
Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.
Ann Hematol
; 100(9): 2387-2398, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34232360
8.
The risk of infections in multiple myeloma before and after the advent of novel agents: a 12-year survey.
Ann Hematol
; 98(3): 713-722, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30680505
9.
Isoform localization of Dectin-1 regulates the signaling quality of anti-fungal immunity.
Eur J Immunol
; 47(5): 848-859, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28303575
10.
Activity of decitabine combined with all-trans retinoic acid in oligoblastic acute myeloid leukemia: results from a randomized 2x2 phase II trial (DECIDER).
Haematologica
; 108(8): 2244-2248, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36601981
11.
Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations: results of the SAL MIDOKIT trial.
Haematologica
; 108(9): 2520-2525, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779591
12.
Staphylococcus intermedius infection with splenic abscesses in a patient with acute lymphoblastic leukemia.
Ann Hematol
; 102(6): 1609-1611, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37014448
13.
Measurement of piperacillin plasma concentrations in cancer patients with suspected infection.
Infection
; 45(5): 629-636, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28516432
14.
HHV-6 encephalitis in a non-transplanted adult acute myeloid leukemia patient.
Ann Hematol
; 100(7): 1895-1897, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33443593
15.
Correction to: Allogeneic hematopoietic stem cell transplantation improves longterm outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.
Ann Hematol
; 100(11): 2877-2878, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34529106
16.
EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia.
Haematologica
; 105(5): e228-e231, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31413097
17.
A 19-year-old patient with atypical chronic myeloid leukemia.
Ann Hematol
; 99(5): 1145-1148, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32193626
18.
Cell transformation by FLT3 ITD in acute myeloid leukemia involves oxidative inactivation of the tumor suppressor protein-tyrosine phosphatase DEP-1/ PTPRJ.
Blood
; 119(19): 4499-511, 2012 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22438257
19.
Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review.
Eur J Haematol
; 93(3): 247-59, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24635656
20.
Synergistic Effects of the RARalpha Agonist Tamibarotene and the Menin Inhibitor Revumenib in Acute Myeloid Leukemia Cells with KMT2A Rearrangement or NPM1 Mutation.
Cancers (Basel)
; 16(7)2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38610989